• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Advanced Enzyme Technologies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 19816.0
  • ISIN : INE837H01020
296.60 3 (0.87%)
  • As on 22 Sep 2026 (EOD)

  • Today’s Low

    295.05

  • Today’s High

    302.70

  • Open

    297.80

  • Perv Close

    294.05

  • 52W Low

    251.95

  • 52W High

    419.00

Key Indicators

  • P/E(TTM)

    40.11

  • Mar.Cap (₹Cr.)

    3,321.21

  • Div & Yield %

    1.80

  • Book Value(₹)

    63.35

  • Debt-Equity Ratio

    0.87

  • AGM Date

    22-Sep-2026

  • EPS

    7.40

  • P/E Ratio

    40.11

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    3,321.21

  • RONW (%)

    10.70

  • ROCE (%)

    14.53

Score Board

  • Equity (₹ in Cr.)

    22.40

  • BV (₹)

    63.40

  • Sales( ₹ in Cr.)

    452.77

  • NP (in Cr.)

    135.03

  • NP Var(%)

    32.0

  • Div%

    268.0

  • CPS (₹)

    13.10

  • EPS (₹)

    12.10

  • Traded Value (₹ in Lakhs)

    3,324.01

  • 52 Week High

    419.00

  • 52 Week Low

    251.95

  • Price BSE

    297.0

  • Price NSE

    297.00

  • Market Capital( in Cr.)

    3,324.01

  • P/C Ratio

    22.60

  • P/E Ratio

    24.60

  • Price Vs.BV

    12.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 452.77 351.41 365.47 311.53 272.80 283.47
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 452.77 351.41 365.47 311.53 272.80 283.47
Other Income 63.39 61.49 58.81 9.81 9.08 6.82
Stock Adjustments 3.08 6.47 7.83 -1.48 13.52 -1.27
Total Income 519.24 419.37 432.11 319.86 295.40 289.02
EXPENDITURE :            
Raw Materials 187.72 148.80 139.56 121.43 112.72 95.03
Power and Fuel Cost 23.69 18.52 22.73 19.58 16.19 11.53
Employee Cost 64.73 56.04 49.39 41.42 39.32 34.23
Other Manufacturing Expenses 20.05 19.74 18.57 14.52 13.53 9.25
Selling and Administration Expenses 44.34 38.17 33.64 32.37 28.66 28.58
Miscellaneous Expenses 8.46 5.67 22.95 5.64 3.08 2.81
Employee Benefit Expenses 64.73 56.04 49.39 41.42 39.32 34.23
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 348.98 286.93 286.83 234.97 213.49 181.44
Operating Profit 170.26 132.44 145.28 84.89 81.90 107.58
Interest 0.50 0.51 0.39 0.33 0.27 0.22
Gross Profit 169.76 131.93 144.89 84.56 81.63 107.36
Depreciation 12.08 11.41 10.90 10.28 9.56 8.93
Profit Before Tax 157.68 120.52 133.99 74.28 72.07 98.43
Current Tax 27.07 16.89 26.95 18.25 18.02 24.84
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.20 1.22 -1.08 0.50 -0.46 2.57
Reported Net Profit 131.81 102.42 108.12 55.53 54.51 71.01
Extraordinary Items -3.22 0.07 -15.13 -0.59 0.89 0.51
Adjusted Net Profit 135.03 102.35 123.25 56.12 53.62 70.50
Adjustment below Net Profit 0.84 -0.34 -0.10 0.49 0.02 -0.03
P & L Balance brought forward 514.66 469.61 417.50 372.66 328.19 263.91
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 58.18 57.03 55.91 11.18 10.06 6.70
P & L Balance carried down 589.13 514.66 469.61 417.50 372.66 328.19
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 267.50 260.00 255.00 50.00 50.00 45.00
Dividend Per Share(Rs) 5.35 5.20 5.10 1.00 1.00 0.90
Earnings Per Share-Unit Curr 11.78 9.15 9.67 4.97 4.88 6.36
Earnings Per Share(Adj)-Unit Curr 11.78 9.15 9.67 4.97 4.88 6.36
Book Value 63.38 56.25 51.91 46.98 42.97 38.97
Book Value(Adj)-Unit Curr 63.38 56.25 51.91 46.98 42.97 38.97

Shareholding Pattern

  • Promoter Group

    43.24%

  • Public Share Holding

    56.76%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 38,738,885 38,738,885.00 38,738,885 38,738,885
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 46,238,885 41.29 46,238,885 6
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,180,625 1.95 2,180,625 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,180,625 1.95 2,180,625 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 13,509,522 12.06 13,509,522 1
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 16,398,013 14.64 16,398,013 74
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 2,041,466 1.82 2,041,466 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 3,311,337 2.96 3,311,337 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 35,260,338 31.49 35,260,338 91
2] Non Institution
Bodies Corporate 1,556,647 1.39 1,556,647 273
Clearing Members 19,580 0.02 19,580 22
Directors of their Relatives 1,903,500 1.70 1,903,500 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,667,288 3.28 3,667,288 1,712
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 628,820 0.56 628,820 1,437
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,635,742 1.46 1,635,742 7
Individuals holding nominal share capital up to Rs. 1 lakh 17,331,700 15.48 17,142,700 59,979
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 552,700 0.49 552,700 2
Others 742,524 0.66 742,524 15
Sub Total 28,296,302 25.27 28,107,302 63,492
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 111,976,150 100.00 111,787,150 63,599

Company Background

Advanced Enzyme Technologies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Advanced Enzyme Technologies Ltd
  • BSE Code : 19816.0
  • ISIN : INE837H01020

  • Incorporation Year

    1989

  • Registered Office

    Sun Magnetica 5th Floor
    Nr LIC Serivce Road Louiswadi, Thane,
    Maharashtra-400604

  • Telephone

    91-22-41703200

  • FAX

    91-22-25835159

  • Chairman

    VASANT RATHI

  • Managing Director

  • Company Secretary

  • Auditor

    MSKA & Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Advanced Enzyme Technologies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Advanced Enzyme 296.85 516.15 452.77 41.46 23.45
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77